share_log

HC Wainwright & Co. Reiterates Buy on ADC Therapeutics, Maintains $9 Price Target

Moomoo 24/7 ·  Apr 15 07:51

HC Wainwright & Co. analyst Robert Burns reiterates ADC Therapeutics (NYSE:ADCT) with a Buy and maintains $9 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment